Pharmacogenomics at the post-pandemic: If not now, then when?
作者信息
Al-Mahayri Zeina N
机构信息
Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
出版信息
Front Pharmacol. 2022 Sep 26;13:1013527. doi: 10.3389/fphar.2022.1013527. eCollection 2022.
Abstract
摘要
相似文献
1
Pharmacogenomics at the post-pandemic: If not now, then when?大流行后的药物基因组学：如果不是现在，那是何时？
Front Pharmacol. 2022 Sep 26;13:1013527. doi: 10.3389/fphar.2022.1013527. eCollection 2022.
2
Pharmacogenomics - a minor rather than major force in clinical medicine.药物基因组学——临床医学中的次要而非主要力量。
Expert Rev Clin Pharmacol. 2024 Mar;17(3):203-212. doi: 10.1080/17512433.2024.2314726. Epub 2024 Feb 6.
3
Implementation of pharmacogenomics: Where are we now?实施药物基因组学：我们现在在哪里？
Br J Clin Pharmacol. 2024 Aug;90(8):1763-1781. doi: 10.1111/bcp.15591. Epub 2022 Dec 16.
4
Building an information system to facilitate pharmacogenomics clinical translation with clinical decision support.建立一个信息系统，通过临床决策支持来促进临床转化。
Pharmacogenomics. 2022 Jan;23(1):35-48. doi: 10.2217/pgs-2021-0110. Epub 2021 Nov 17.
5
A semi-supervised approach to extract pharmacogenomics-specific drug-gene pairs from biomedical literature for personalized medicine.一种从生物医学文献中提取用于个性化医疗的药物-基因对的半监督方法。
J Biomed Inform. 2013 Aug;46(4):585-93. doi: 10.1016/j.jbi.2013.04.001. Epub 2013 Apr 6.
6
Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives.在卡塔尔开创精准医学之路：从公共卫生角度看药物基因组学计划。
Front Public Health. 2024 Mar 14;12:1364221. doi: 10.3389/fpubh.2024.1364221. eCollection 2024.
7
Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.临床药物基因组学检测在下一代测序时代：精准医学的挑战和机遇。
Expert Rev Mol Diagn. 2018 May;18(5):411-421. doi: 10.1080/14737159.2018.1461561. Epub 2018 Apr 23.
8
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada.加拿大马尼托巴省药剂师对药物基因组学的认识和看法。
Pharmacogenomics. 2024 Mar;25(4):175-186. doi: 10.2217/pgs-2024-0013. Epub 2024 Mar 20.
9
An interprofessional education experience to promote the role of the pharmacist in precision medicine.一次促进药剂师在精准医学中作用的跨专业教育经历。
Curr Pharm Teach Learn. 2021 Oct;13(10):1370-1375. doi: 10.1016/j.cptl.2021.07.017. Epub 2021 Jul 24.
10
Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.系统评价遗传药理学指导心血管疾病治疗的成本效益的证据。
Genet Med. 2020 Mar;22(3):475-486. doi: 10.1038/s41436-019-0667-y. Epub 2019 Oct 8.
本文引用的文献
1
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?药物遗传学的应用能否提高新冠病毒肺炎的治疗效率？
Pharmaceuticals (Basel). 2022 Jun 13;15(6):739. doi: 10.3390/ph15060739.
2
Pharmacogenetic variants and risk of remdesivir-associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID-19.在因 COVID-19 住院的百万退伍军人计划参与者中，药物遗传学变异与瑞德西韦相关肝酶升高的风险。
Clin Transl Sci. 2022 Aug;15(8):1880-1886. doi: 10.1111/cts.13313. Epub 2022 Jun 9.
3
Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.自然选择对 SARS-CoV-2 感染相关基因的全球遗传变异模式及与临床表型关联的影响。
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2123000119. doi: 10.1073/pnas.2123000119. Epub 2022 May 17.
4
Mendelian randomization in pharmacogenomics: The unforeseen potentials.孟德尔随机化在药物基因组学中的应用：意料之外的潜力。
Biomed Pharmacother. 2022 Jun;150:112952. doi: 10.1016/j.biopha.2022.112952. Epub 2022 Apr 13.
5
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.用于改善新冠病毒疾病治疗的药物遗传学和精准医学方法。
Front Pharmacol. 2022 Feb 18;13:835136. doi: 10.3389/fphar.2022.835136. eCollection 2022.
6
Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.华法林药物基因组学在南非真实临床实践中的精准医学应用：利用 29 个药物基因中的 73 个变异体。
OMICS. 2022 Jan;26(1):35-50. doi: 10.1089/omi.2021.0199. Epub 2021 Dec 24.
7
The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations.撒哈拉以南非洲人群中药物代谢动力学（ADME）基因变异的程度及影响
Front Pharmacol. 2021 Apr 28;12:634016. doi: 10.3389/fphar.2021.634016. eCollection 2021.
8
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.新冠病毒治疗药物的印度人群基因组药物基因组学全景。
Pharmacogenomics. 2021 Jul;22(10):603-618. doi: 10.2217/pgs-2021-0028. Epub 2021 Jun 18.
9
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.可操作的药物基因组全基因组孟德尔随机化确定了 COVID-19 的再利用机会。
Nat Med. 2021 Apr;27(4):668-676. doi: 10.1038/s41591-021-01310-z. Epub 2021 Apr 9.
10
Pharmacogenetics Approach for the Improvement of COVID-19 Treatment.药物遗传学方法在改善 COVID-19 治疗中的应用。
Viruses. 2021 Mar 5;13(3):413. doi: 10.3390/v13030413.
Zotero 插件